Andrew Hill
senior visiting Research Fellow in the Department of Molecular and Clinical Pharmacology at the University of Liverpool (England)
Research
Pandemic Research
Minimum manufacturing costs, national prices and estimated global availability of new repurposed therapies for COVID-19
Systematic Review and Meta-Analysis of Ivermectin Safety Profile in COVID-19 Trials
Ivermectin for the prevention of COVID-19: addressing potential bias and medical fraud
Expression of Concern: “Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection”
Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection
Ivermectin Efficacy
MOVe-OUT Clinical Trial
A paper authored by Kristian Thorlund, Kyle Sheldrick, Gideon Meyerowitz-Katz, Sonal Singh, and Hill critiqued the MOVe-OUT clinical trial studying molnupiravir.1)
Presentations
Ivermectin meta-analysis by Dr. Andrew Hill EXTENDED Jan 20, 2021
1)
March 11, 2022 | Kristian Thorlund et al | American Journal of Tropical Medicine and Hygiene | Making Statistical Sense of the Molnupiravir MOVe-OUT Clinical Trial | doi: 10.4269/ajtmh.21-1339